课题基金 / 基金详情

STING-Dependent Pathways Restraining Severe Schistosome Immunopathology

STING-Dependent Pathways Restraining Severe Schistosome Immunopathology
STING 依赖性通路抑制严重血吸虫免疫病理学
批准号:
10531293
负责人:
Parisa Kalantari
金额:
$50.16万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-02-14 至 2026-01-31
关键词:
AddressAftercareAgonistAnti-Inflammatory AgentsAntigen-Presenting CellsAntigensAreaBindingBone MarrowBypassC Type Lectin ReceptorsCD4 Positive T LymphocytesCell ShapeCellsCessation of lifeChromatinCoculture TechniquesCyclic GMPCytokine ActivationDNAData SetDendritic CellsDetectionDevelopmentDiseaseDrug resistanceElementsFibrosisFlow CytometryFutureGene Expression ProfileGenetic TranscriptionGoalsGranulomaGranulomatousHemorrhageHepaticHepatosplenomegalyHumanIFNAR1 geneIRF3 geneImmuneImmune responseInbred CBA MiceInfectionInflammationInflammatoryInflammatory ResponseInnate Immune ResponseInterferon Type IInterferonsInterleukin-17IntestinesLesionLiverMass Spectrum AnalysisMediatingMinorityMolecularMorbidity - disease rateMusNucleotidesParasite resistanceParasitesParasitic DiseasesPathogenicityPathologyPathway interactionsPatientsPeriodicityPharmacologyPlayPolysaccharidesReactionRecurrenceReporterReportingResearchRoleSchistosomaSchistosoma mansoniSchistosomiasisSeveritiesShapesSignal TransductionSite-Directed MutagenesisStimulator of Interferon GenesT-LymphocyteT-Lymphocyte SubsetsTestingTh2 CellsTissuesVaccinesVariantVertebratesWidespread Diseaseadaptive immune responsebasecell mediated immune responsecell typecytokinedesigneggexperimental studygastrointestinal symptomhuman diseaseimmunopathologyin vitro testingin vivoinnate immune mechanismsinnovationinsightmortalitymouse modelnext generation sequencingnovelpreventpromoterresponsesensortranscription factortranscriptometranscriptome sequencingtreatment strategy

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Schistosomiasis is a major tropical parasitic disease caused by trematode worms of the genus Schistosoma. The etiopathology of schistosomiasis results from an inflammatory response to the tissue-trapped parasite eggs. Morbidity and mortality in infection with Schistosoma mansoni are due to a pathogenic CD4 T cell- mediated immune response against egg components, which results in granuloma formation and fibrosis in the liver and intestines. The spectrum of pathology ranges from mild gastrointestinal symptoms in most cases to severe hepatosplenomegaly, hemorrhage and death in a minority of patients. This variation also exists in mouse model of schistosomiasis where CBA mice develop severe egg induced immunopathology driven by IL-17-producing T cells (Th17 cells); while C57BL/6 (BL/6) mice develop milder lesions driven by Th2 cells. We propose to investigate a novel immune mechanism that protects the host from developing severe immunopathology. This is based on our observation that in BL/6 mice, the mild pathology is associated with a protective type I Interferon (IFN) response that is dependent on STING, an adaptor molecule that functions to detect the presence of cytosolic egg-derived DNA. Indeed, BL/6 mice deficient in STING, develop significantly larger hepatic lesions. The inhibitory effect of STING is via targeting CD209a, a C-type lectin receptor on APCs, which we recently reported to be associated with severe pathology. Based on these novel observations, we hypothesize that STING related pathways promote the development of antigen presenting cell (APC)s that contribute to reduced inflammation. Specific Aim 1 of the proposal is to define the role of the cGAS/STING pathway in suppressing egg-induced immunopathology. Specific Aim 2 is to elucidate how STING modulates CD209a expression. The proposed experiments represent a concerted effort to unravel novel innate immune mechanisms affording host protection in schistosomiasis, a heretofore unexplored area of research in this disease and other Th17 driven inflammatory diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金